Advertisement
The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
  • E-mail E-Mail
  • Printer Friendly Printable Single-Page
  • Glossary Glossary
  • Bookmark and Share Share
Henry J. Kaiser Family Foundation • International News

GlaxoSmithKline Spokesman Defends Company's Position on Patent Pools for HIV in Guardian Letter to the Editor

September 10, 2009

In a Guardian letter-to-the editor, Chris Strutt of GlaxoSmithKline responds to the newspaper's recent coverage of the GSK's position on a patent pool for HIV medicines. "Contrary to the impression given in your report ... GSK has been in discussions with UNITAID to better understand their objectives regarding an HIV patent pool," Strutt writes, adding, "We are in no way complacent about HIV ... Fighting this disease requires a multilateral approach and we are fully committed to playing our part" (Strutt, 9/10).

Back to other news for September 2009

Search the Newsroom archive


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.


This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report.
  • E-mail E-Mail
  • Printer Friendly Printable Single-Page
  • Glossary Glossary
  • Bookmark and Share Share

See Also
Read More About Generic/Discount HIV Drug Access in the Developing World
Read More About HIV/AIDS Drug Patents Policy

 

Advertisement